Stem Cell Breakthrough Could Reopen Clone Wars
By Editorial,
New Scientist
| 01. 29. 2014
It didn't take long after Dolly the sheep was cloned in 1996 for maverick scientists to start talking about cloning humans.
One, Severino Antinori, attracted
global condemnation when he announced plans to use cloning to help infertile couples. Critics of the idea argued that vital questions had to be answered first: about the health of the progeny, their identity and, for those so inclined, the spiritual dimensions.
Those clones never arrived: the technology was not up to it. But now comes news that biologists have turned mature animal cells into something resembling "totipotent" stem cells – and are trying to do the same with human cells (see "
Stem cell power unleashed after 30 minute dip in acid").
Totipotent cells are the most versatile of all stem cells; a single one can develop into an embryo with a placenta, and hence give rise to a fully formed animal – in other words, a clone. The researchers do not use the word "totipotent" and have no stated intention of cloning a human. But the research seems to have reopened the...
Related Articles
By Ian Sample, The Guardian | 03.08.2024
Scientists are a step closer to making IVF eggs from patients’ skin cells after adapting the procedure that created Dolly the sheep, the first cloned mammal, more than two decades ago.
The work raises the prospect of older women being...
By Ramon Antonio Vargas, The Guardian | 02.28.2024
Doctors say a man in California who contracted blood cancer while living with HIV is in remission from both potentially fatal illnesses thanks to a treatment they are hailing as remarkable and encouraging.
Paul Edmonds is only the fifth-known person...
By Victoria Gray, Uduak Thomas, and Kevin Davies, The CRISPR Journal | 02.14.2024
In July 2019, medical staff in Nashville dosed the first U.S. patient in the exa-cel therapy trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. That first patient was Victoria Gray, a mother of four from Forest, Mississippi, a sickle cell...
By Adam Zewe, MIT News | 02.07.2024
A tiny device built by scientists at MIT and the Singapore-MIT Alliance for Research and Technology could be used to improve the safety and effectiveness of cell therapy treatments for patients suffering from spinal cord injuries.
In cell therapy, clinicians...